CHICAGO and ATLANTA, December 11, 2019 — Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced the acquisition of AKESOgen, an industry-leading commercial laboratory facility and provider of genomics and clinical trial precision medicine services based in Atlanta. AKESOgen is an integrated genomics, genetics, and biobanking […]
Share this 
Dr. Bouzyk was invited by the College of American Pathologists to be on the faculty and a speaker for this International Education Program where participants came from various laboratories in South America including Brazil and Argentina. Pictured with Dr. Mark Bouzyk (Left to Right): Dr. Leonas Bekeris (CAP Regional Commissioner, South America and Mexico), Denise […]
Share this 
NEW YORK, Feb. 13, 2019 — RenalytixAI (AIM: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, today announced the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility and provider of clinical trial precision medicine services located in Atlanta, Georgia. AKESOgen brings a state-of-the-art 14,000 square foot CLIA1 […]
Share this 
AKESOgen, Inc. Selected as a 2018 Atlanta Metro Export Challenge Winner AKESOgen, Inc. Receives $5,000 Grant to Grow Internationally ATLANTA – November 6th, 2018 AKESOgen, Inc. is a recipient of a $5,000 grant in the annual Atlanta Metro Export Challenge (Atlanta MEC), a grant program designed to engage small- and medium-sized businesses in metro Atlanta […]
Share this 
All New DNA Body Blueprint Provides Integrated Personal Action Plan Focusing on Genetic-Based Eating Behaviors, Nutrition and Metabolism Simple, Effective and Secure At-Home DNA Test is Supported by Science and Comprehensively Developed to Help Weight Loss and Weight Management FORT WASHINGTON, Pa.-Nutrisystem, Inc. (Nasdaq: NTRI), a leading provider of health and wellness and weight management products and […]
Share this 
Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Disease Risk to Include Saliva Samples Pioneering polygenic risk scoring approach verified for banked DNA, blood and saliva samples 8th May 2018: Oxford & Manchester, UK and Atlanta, GA. Cytox, a precision medicine testing company which today is commercializing polygenic risk scoring […]
Share this 
AKESOgen recognized as Georgia Small Business Rock Star ATLANTA – March 19, 2018—AKESOgen was recognized by the state of Georgia as a Small Business Rock Star today at a luncheon hosted by the Georgia Department of Economic Development (GDEcD) and the Georgia Economic Developers Association (GEDA). “What an honor it is to […]
Share this 
AKESOgen is very excited to announce that on August 16, 2017, they were featured on Times Square in NYC! Share this
Share this 
Thermo Fisher Scientific Showcases Large-scale Precision Medicine Research Studies in Genotyping http://www.prweb.com/releases/2017/09/prweb14726130.htm In this webinar, which LabRoots will host October 25, attendees will gain a better understanding of how the recently developed Axiom Precision Medicine Research Array can be used in a wide variety of disease and therapeutic research areas. Yorba Linda, Ca (PRWEB) September […]
Share this 
AKESOgen delegates attended ASHG meeting in Orlando Oct 17-21, 2017 Share this
Share this 